PillRx only · Capsule, Extended Release · Oral
Memantine Hydrochloride
Memantine Hydrochloride
9 ACTIVE SUPPLIERS — US
openFDA · updated weekly
US35 NDCs
9 active makers
9 active makers
UKComing
soon
soon
CAComing
soon
soon
AUComing
soon
soon
EUComing
soon
soon
ATC—
RxCUI (US)—
US makers10 labelers
Packages71
DEA / ScheduleNone
US acquisition costNADAC · per unit
Average across 36 priced NDCs. A benchmark of pharmacy acquisition cost — not a retail quote.
$0.362
Latest avg · Jun 17, 2026
-9%
Since Dec 17, 2025
9
Active US suppliers
34%
Top-2 supplier share*
Who makes it9 active · 1 exited
US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.
| Labeler | Type | Packages | Status |
|---|---|---|---|
| Amneal Pharmaceuticals LLC | unknown | 12 | SUPPLYING |
| Zydus Pharmaceuticals USA Inc. | unknown | 12 | SUPPLYING |
| Zydus Lifesciences Limited | unknown | 12 | SUPPLYING |
| Aurobindo Pharma Limited | unknown | 8 | SUPPLYING |
| Macleods Pharmaceuticals Limited | unknown | 8 | SUPPLYING |
| Slate Run Pharmaceuticals, LLC | unknown | 6 | SUPPLYING |
| Lupin Pharmaceuticals,Inc. | unknown | 6 | SUPPLYING |
| Vitruvias Therapeutics | unknown | 4 | SUPPLYING |
| Major Pharmaceuticals | unknown | 2 | SUPPLYING |
| NCS HealthCare of KY, LLC dba Vangard Labs | unknown | 1 | EXITED 2026 |
Regulatory & supply events
No recalls, shortages, or registration changes on record for this drug concept.